Pharmala Biotech Holdings Inc. (MDMA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40 | 419 | 195 | 852 | 2,472 |
| Marketable Securities | 920 | N/A | N/A | N/A | N/A |
| Receivables | 264 | 211 | 223 | 51 | 60 |
| Inventories | 370 | 354 | 122 | 116 | 0 |
| Other current assets | 28 | 0 | 0 | 0 | 0 |
| TOTAL | $1,647 | $1,043 | $714 | $1,085 | $2,532 |
| Non-Current Assets | |||||
| PPE Net | 3 | 0 | 2 | 4 | 2 |
| Intangibles | 1,770 | 1,854 | 1,696 | 1,241 | 260 |
| TOTAL | $1,773 | $1,855 | $1,699 | $1,245 | $262 |
| Total Assets | $3,420 | $2,898 | $2,413 | $2,330 | $2,794 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 366 | 358 | N/A | N/A | N/A |
| Accrued Expenses | 193 | 193 | N/A | N/A | N/A |
| TOTAL | $962 | $917 | $1,029 | $424 | $138 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 403 | 366 | 443 | 52 | 0 |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $962 | $917 | $1,029 | $424 | $138 |
| Shareholders' Equity | |||||
| Common Shares | 7,452 | 5,695 | 5,140 | 4,832 | 2,196 |
| Retained earnings | -7,131 | -4,956 | -4,132 | -3,495 | -2,509 |
| Other shareholders' equity | 1,228 | 381 | 0 | 190 | 2,826 |
| TOTAL | $2,458 | $1,981 | $1,384 | $1,906 | $2,655 |
| Total Liabilities And Equity | $3,420 | $2,898 | $2,413 | $2,330 | $2,794 |